Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy

NRx Pharmaceuticals Inc (NASDAQ:NRXP) has filed a new Breakthrough Therapy designation request with the FDA for Zyesami focused on a subgroup of critical COVID-19 patients. The subgroup includes patients who were also treated with Gilead Sciences Inc's (NASDAQ:GILD) Veklury (remdesivir) in addition to aviptadil or placebo. The request includes safety data on approximately 750 patients…

Benzinga

Mattel Debuts Barbie Version Of Queen Elizabeth

As Queen Elizabeth II celebrates her 96th birthday, Mattel Inc. (NASDAQ: MAT) has issued a new Barbie doll inspired by the British monarch.

Benzinga

Expert Ratings for Alkermes

Alkermes (NASDAQ:ALKS) has observed the following analyst ratings within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

If You Invested $100 In CSX 15 Years Ago, Here's How Much You Would Have Today

CSX (NASDAQ:CSX) has outperformed the market over the past 15 years by 6.88% on an annualized basis producing an average annual return of 14.46%. Currently, CSX has a market capitalization of $80.37 billion.

Benzinga

If You Invested $1000 In Fastenal 20 Years Ago, Here's How Much You Would Have Today

Fastenal (NASDAQ:FAST) has outperformed the market over the past 20 years by 5.4% on an annualized basis producing an average annual return of 12.78%. Currently, Fastenal has a market capitalization of $33.33 billion.

Benzinga

Where SEI Investments Stands With Analysts

Analysts have provided the following ratings for SEI Investments (NASDAQ:SEIC) within the last quarter:

Benzinga

Earnings Preview: First Hawaiian

First Hawaiian (NASDAQ:FHB) is set to give its latest quarterly earnings report on Friday, 2022-04-22. Here's what investors need to know before the announcement. Analysts estimate that First Hawaiian will report an earnings per share (EPS) of $0.42.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Ominous Death Cross Forms On Qualcomm's Chart

If history is any guide, there may be trouble ahead for shares of Qualcomm (NASDAQ:QCOM). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On NVIDIA's Chart

If history is any guide, there may be trouble ahead for shares of NVIDIA (NASDAQ:NVDA). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Overview Of Value Stocks In The Financial Services Sector

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

This Foreboding Sign Looms Over Datadog's Chart

If history is any guide, there may be trouble ahead for shares of Datadog (NASDAQ:DDOG). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On Biomarin Pharmaceutical's Chart

If history is any guide, there may be trouble ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Prospect Capital: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Prospect Capital (NASDAQ:PSEC).

Benzinga

Krispy Kreme: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Krispy Kreme (NASDAQ:DNUT).

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Amazon, SpaceX And Others Win $279M In NASA Contracts

Amazon.com Inc's (NASDAQ:AMZN) satellite venture, Tesla Inc (NASDAQ:TSLA) CEO Elon Musk-led SpaceX's Starlink network, and other satellite firms won a combined $278.5 million in contracts from NASA to demonstrate communications in space. Amazon's Project Kuiper, a planned network of over 3,000 satellites built to beam broadband internet to remote regions, won $67 million, Reuters reports. SpaceX's…

Benzinga

EXCLUSIVE: Why Canopy Growth's CEO Says US Cannabis Industry Can Reach 'Same Size As The Beer Industry'

Canopy Growth Corp (NASDAQ: CGC) and Wana Brands are positioning themselves to be U.S.

Benzinga

Monday Is Your Last Chance To Buy Cal-Maine Foods Before The Dividend Payout

Monday marks the last chance for investors to receive the next dividend payout from Cal-Maine Foods (NASDAQ:CALM).

Benzinga

Fastenal: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Fastenal (NASDAQ:FAST).

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Lexaria Posied To Receive US Patent For DehydraTECH To Deliver Antiviral Drugs

Lexaria Bioscience Corp (NASDAQ:LEXX) is receiving its first-ever patent for DehydraTECH technology in the enhanced delivery of antiviral drugs. Lexaria has received notification from the United States Patent and Trademark Office that patent 11,311,559 for Compositions and Methods For Enhanced Delivery Of Antiviral Agents will be issued to the Company on April 26. "This…

Benzinga

Where FTC Solar Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on FTC Solar (NASDAQ:FTCI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

If You Invested $100 In AstraZeneca 5 Years Ago, Here's How Much You Would Have Today

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 4.24% on an annualized basis producing an average annual return of 17.72%. Currently, AstraZeneca has a market capitalization of $213.61 billion.

Benzinga

Gentex Earnings Preview

Gentex (NASDAQ:GNTX) is set to give its latest quarterly earnings report on Friday, 2022-04-22. Here's what investors need to know before the announcement. Analysts estimate that Gentex will report an earnings per share (EPS) of $0.32.

Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

What 4 Analyst Ratings Have To Say About Intra-Cellular Therapies

Analysts have provided the following ratings for Intra-Cellular Therapies (NASDAQ:ITCI) within the last quarter:

Benzinga

Tilray's Breckenridge Distillery Wins Two Double Gold And One Gold Medal At The San Francisco World Spirits Competition

Breckenridge Distillery, subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), celebrates two Double Gold and one Gold medal at the 2022 San Francisco World Spirits Competition.

1 … 663 664 665 666

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.